The semaglutide shortage has officially ended in the US—which means the GLP-1 drug industry is about to undergo massive changes.

Novo Nordisk's (NVO) weight loss therapy Wegovy/Ozempic come out of shortage, but the FDA won't crack down on compounders ...

Treatment for OUD is currently dominated by opioid agonist therapies that are highly regulated due to their liability for ...

Many of these unlawful and unauthorized shipments were explicitly tagged for compounding, which in turn could put many ...

Conagra and General Mills are among the food companies offering special options for people on GLP-1 drugs, but the products ...

Weight loss injections have become incredibly popular in the last year or so. In fact, these medications are so widely used ...

Peptide therapy enhances targeted medicine, utilizing specific peptides for effective treatment of cancer, metabolic disorders, and neurodegenerative diseases.

GLP-1 medications initially were used to help people with diabetes improve their insulin resistance and hunger cravings.

The GLP-1 liraglutide showed potential benefit in reducing stroke recurrence and improving functional outcomes after minor ...

A recent study found that over a third of websites selling compounded diabetes and weight loss medications, such as Ozempic ...

Axplora operates nine API manufacturing sites across Europe and India, with the goal of providing multi-site capacity to partners worldwide.

A latest research led by Dr Shuyao Zhang, an assistant professor of internal medicine at UT Southwestern in Dallas reveal the ...